Natriumchlorid Noridem (Sodium Chloride)

Sodium chloride, the active ingredient in Natriumchlorid Noridem, is an electrolyte presented as an injection solution for intravenous use. It is employed to restore extracellular sodium and chloride levels, supporting fluid and electrolyte balance in patients with hypovolemia or electrolyte disturbances.

GNH USA supplies Natriumchlorid Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from consistent product availability, regulatory compliance, and dedicated technical support throughout the supply chain.

Natriumchlorid Noridem is used in the management of conditions involving fluid loss or electrolyte imbalance. - Fluid and electrolyte replacement: Restores sodium and chloride concentrations to maintain intravascular volume and osmolar balance. - Hypovolemia: Replenishes circulating fluid volume in patients with blood loss or dehydration. - Electrolyte imbalance: Corrects low serum sodium or chloride levels in various clinical settings.

Intravenous sodium chloride may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Hypernatremia: Elevated serum sodium leading to thirst or mild neurological symptoms. - Hypertension: Transient increase in blood pressure during infusion. - Phlebitis: Local vein inflammation at the infusion site. - Pain at injection site: Discomfort or burning sensation during administration. - Edema: Mild peripheral swelling due to fluid shift.

Serious or Rare Side Effects: - Volume overload: Pulmonary edema or heart failure exacerbation in susceptible patients. - Severe hypernatremia: Neurological impairment, seizures, or coma. - Anaphylactoid reaction: Rare hypersensitivity with rash, hypotension, or respiratory distress. - Electrolyte disturbances: Rapid shifts causing arrhythmias.

Prior to administering Natriumchlorid Noridem, several safety considerations should be observed. - Assess fluid status: Evaluate patient’s volume status and cardiac function before infusion. - Monitor electrolytes: Check serum sodium and chloride levels regularly during therapy. - Adjust for renal impairment: Reduce infusion rate or volume in patients with reduced kidney function. - Caution with heart failure: Avoid rapid large-volume infusions in patients with congestive heart failure. - Avoid concurrent hypertonic solutions: Do not mix with other high‑sodium or hypertonic fluids. - Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Sodium chloride infusion can interact with other medications or solutions, influencing electrolyte balance or cardiovascular status.

Major Interactions (Avoid): - Hypertonic saline solutions: Co‑administration may cause severe hypernatremia. - Potassium chloride IV: Combined high sodium and potassium loads can precipitate cardiac arrhythmias. - ACE inhibitors or ARBs: May enhance risk of hyperkalemia when potassium supplements are also given.

Moderate Interactions (Monitor Closely): - Diuretics: May require adjustment of sodium chloride volume to maintain electrolyte balance. - Corticosteroids: Can increase sodium retention, necessitating careful monitoring. - Calcium channel blockers: May potentiate blood pressure changes when large fluid volumes are infused.